We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Zynerba Pharmaceuticals Inc | NASDAQ:ZYNE | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.30 | 1.30 | 1.24 | 0 | 01:00:00 |
Sunday, December 3, 2017 Poster title: “Synthetic Transdermal Cannabidiol for the Treatment of Focal Epilepsy in Adults”Poster session: 2 Poster number: 428Author presentation time: 12:00PM – 2:00PM EST Display time: 10:00AM – 4:00PM EST Location: Hall B, Lower LevelAbstract ID: 2.428
About Zynerba Pharmaceuticals, Inc. Zynerba Pharmaceuticals (NASDAQ:ZYNE) is dedicated to improving the lives of people with severe health conditions where there is a high unmet medical need by developing and commercializing pharmaceutically-produced transdermal cannabinoid medicines designed to meet the rigorous efficacy and safety standards established by global regulatory agencies. Through the discovery and development of these life-changing medicines, Zynerba seeks to improve the lives of patients battling severe, chronic health conditions including epilepsy, Fragile X syndrome, osteoarthritis, fibromyalgia and peripheral neuropathic pain. Learn more at www.zynerba.com and follow the Company on Twitter at @ZynerbaPharma.
Zynerba ContactWill Roberts, VP Investor Relations and Corporate Communications484.581.7489robertsw@zynerba.com
Media contactTheresa Dolge Tonic Life CommunicationsOffice: 215-928-2748Theresa.Dolge@toniclc.com
1 Year Zynerba Pharmaceuticals Chart |
1 Month Zynerba Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions